Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check78 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check93 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed information about a clinical trial involving the IDO1 inhibitor BMS-986205 and nivolumab for treating liver cancer, while adding new identifiers and collaborators related to the study.SummaryDifference47%
Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.